News & Events
- National Conference on Engaging Patients, Families, and Communities in all Phases of Translational Research to Improve Health
National Conference on Engaging Patients, Families, and Communities in all Phases of Translational Research to Improve Health
August 21-22, 2014
Thursday: 7:30 a.m. to 5:00 p.m.
Friday: 7:30 a.m. to 12:15 p.m.
Bethesda North Marriott Hotel and Conference Center
5701 Marinelli Road
Bethesda, Md. 20852
The goal of this conference is to present and compare perspectives and examples of methods of engagement in research that include individuals, including patients and families, to community organizations and disease advocates, as well as clinicians and other health professionals. Attendees for this conference will include community groups, patient advocacy groups, funders and foundations that are interested in research design and outcomes, and the researchers who presently work with these groups or wish to do so in the future.
September 19, 2014
8:30 a.m. to 5:00 p.m.
National Institutes of Health
Building 31C, 6th Floor, Conference Room 6
Bethesda, Md. 20852
This joint meeting of the NCATS Advisory Council and Cures Acceleration Network (CAN) Review Board will feature reports from NCATS Director Christopher P. Austin, M.D., and others about the Center’s initiatives, policies, programs and future direction. For more information about the Advisory Council and CAN Review Board, visit the NCATS Advisory Council page and the Cures Acceleration Network Review Board page of this site.
October 23, 2014
8:45 a.m. to 4:35 p.m.
Novartis Institutes for Biomedical Research
250 Massachusetts Avenue
Cambridge, Mass. 02139
This one-day conference addresses a critical and timely topic in preclinical drug discovery: “A growing chorus of concern, from scientists and [the public], contends that the complex system for ensuring the reproducibility of biomedical research is failing and is in need of restructuring.”
The conference in planned around a series of talks and panels by industry, academia and government scientists, as well as editors from leading journals to lend perspective and brainstorm practical solutions. As an open forum, it is expected to bring together key biomedical scientists and stakeholders as a community with a keen interest in this topic.